# CytomX Therapeutics (CTMX) — Overview

CTMX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/ctmx

## Price

Last close $2.41 on Oct 15, 2026. 52-week range $2.23 – $6.75.

## Company profile

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $18.3M |
| Revenue (quarter) | $1.4M |
| Revenue growth (year over year) | -92.40% |
| Gross profit (trailing twelve months) | $18.3M |
| Gross margin | 100.00% |
| Net income (trailing twelve months) | −$79.7M |
| Net income (quarter) | −$20.7M |
| Net income growth (year over year) | -13319.48% |
| Net margin | -435.19% |
| Return on equity | -39.18% |
| EPS (trailing twelve months) | −$0.57 |
| Book value per share | $1.39 |
| P/E (trailing twelve months) | — |
| Price to book | 1.7 |
| Debt to assets | 20.76% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is CytomX Therapeutics (CTMX) profitable?

No. CytomX Therapeutics reported a net loss of $79.7M over the trailing twelve months.

### How much revenue does CytomX Therapeutics (CTMX) make?

CytomX Therapeutics generated $18.3M in revenue over the trailing twelve months, down 92.40% year over year.

### How do I buy stock in CytomX Therapeutics (CTMX)?

CTMX trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).